Incidence of measles specific IgG antibody among children in Adamawa State, Nigeria
DOI:
https://doi.org/10.47430/ujmr.1941.004Keywords:
IgG antibody,, Immunity,, Measles virus,, Vaccination.Abstract
Measles account for nearly half of the 1.7 million annual deaths due to childhood vaccine- preventable diseases. Presence of measles specific IgG antibodies has been proven to correlate with protection (immunity) to natural measles infection. This study was therefore designed to determine the prevalence of measles specific IgG antibody and also to determine the association between prevalence of measles specific IgG antibody and age, gender, as well as history of measles infection among children aged 0-14 years in Adamawa State. The research was carried out within the three senatorial districts of the State. Serum samples (368) collected from children were used to determine the prevalence using ELISA method. Questionnaire was used to obtain demographic data of the children relevant to the study. The study revealed that 227 (61.6%) of the children had protective measles IgG antibody with antibody titre ranging from 10-250 U/mL, while 141 (38.4%) had non-protective measles IgG antibody. There was significant association between history of measles infection and protective antibodies (P-value=0.000), but there was no significant association between gender (P-value = 0.958), age (P- value = 0.140) and protective measles IgG antibody.
Downloads
References
Anna, R., Simona, A., Antonella D., Luciana, G. and Marina V. (2016). The influence of sex and gender on immunity, infection and vaccination. Ann Ist Super Sanità. 52 (2): 198-204
Centre for Disease Control and Prevention (2015). Measles: Questions and Answers. Information about the disease and vaccine. Retrieved from www.vaccineinformation.org/catg.d/p4 209.pdf on 10th March, 2015.
Coetzee, S. (2013). A retrospective review of patients admitted to the paediatric ICU at Red Cross war memorial children's Hospital during 2010 with the clinical diagnosis of measles or measles-related complications. PhD. thesis Published by university of Cape Town (UCT) in terms of non-exclusive license granted to UCT by the author.
Demanou, M., Ratsitoharana, R., Yonga, M., Desseh, A., Anya, B., Kobela, M., and Njoum, R. (2013). Molecular characterisation of measles viruses that circulated in Cameroon between 2010 and 2011.Virology Journal 10(71):21-26
https://doi.org/10.1186/1743-422X-10-71
Demeditect Diagnostics (2015). Measles IgG ELISA (DEMSA01) for the detection and quantitative determination of human IgG antibodies against measles virus in serum and plasma. Product information/ user manual.
Eghafona, N.O., Ahmad, A.A., Odama, L.E., Onuora C., Gosham L.T., Emejuaiwe, S.O., and Woghiren, E.I. (1987). The levels of measles antibodies in Nigerian children aged 0-12 months and its relationship with maternal parity. Journal of Epidemiology and Infection 99: 547-550.
https://doi.org/10.1017/S0950268800068047
Hamid, K.M., Mukhtar, M.D., Arzai, A.H., Yusuf, I. , Mohammed, A.H., Mainasara, A.S., and Tofa, U.S. (2012). Serological evaluation of immunity against measles in children attending Murtala Mohammed Specialist Hospital, Kano- Nigeria. International Scientific Research Journal 4: 8-15.
Mossong, J. and Muller, C.P. (2003). Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine 21:4597-4603.
https://doi.org/10.1016/S0264-410X(03)00449-3
Naing, L., Winn, T. And Rusli, B. N. (2006). Practical issues in calculating the sample size for prevalence studies. Archiives of Orofacial Sciences 1:9-14.
Perry, R.T. and Haisey N.A. (2004). The clinical significance of measles. Journal of Infectious Diseases 189 (suppl.1), 4-16.
https://doi.org/10.1086/377712
Schluderberg, A., Lamm, S.H., and Landrigan, P.J. (1973). Measles immunity in children vaccinated before one year of age. American Journal of Epidemiology. 97:402-409
https://doi.org/10.1093/oxfordjournals.aje.a121521
Shohat, T., Green, M.S., Nakar, O., Ballin, A., Duvdevani, P., Cohen, A. et al. (2000). Gender differences in the reactogenicity of measles-mumps- rubella vaccine. Isreali Medical Association Journal. 2:192-5.
Weldegebriel, G.G., Gasasira, A., Harvey, P., Masresha, B., Goodson, J.L., Pate, A.M., Abanida, E. and Chevez, A. (2011). Measles resurgence following a nationwide measles vaccination campaign in Nigeria 2005-2008. Journal of Infectious Diseases 204(1): 226-231.
https://doi.org/10.1093/infdis/jir136
Whittle, H.C., Aaby, P., Samb, B., Jensen, H., Bennett, J., Simondon, F. (1999).Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet 353:98- 101.
https://doi.org/10.1016/S0140-6736(98)02364-2
World Health Organization (2000). Manual for the laboratory diagnosis of measles virus infection. Geneva, Switzerland: WHO/V&B/00.16.
World Health Organisation (2001). Global Measles Mortality Reduction and Regional Elimination Strategic Plan 2001-2005. Geneva, Switzerland.
World Health Organization (2008). Immunological Basis for Immunization Series Module xx: Measles. Geneva, Switzerland
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
